鶹ýӰ

Epstein-Barr and MS; When Lewy Pathology Starts; Alzheimer's Blood Test Assessed

— News and commentary from the world of neurology and neuroscience

MedpageToday
Neuro Break over a computer rendering of neurons.

Antibody response to anti-Epstein-Barr virus nuclear antigen 1 (EBNA-1) may be a (MS), a small study suggested. (JAMA Neurology)

ND0612, a subcutaneous , increased on time without troublesome dyskinesia and reduced off time when used in combination with oral immediate-release levodopa-carbidopa in a phase III trial. (Lancet Neurology)

A forensic autopsy study showed that started in middle age. (Annals of Neurology)

Researchers showed how the brain coordinates in mice. (Science)

Risks of cerebral hemorrhage with anti-amyloid drugs like lecanemab (Leqembi) suggest a need to create for Alzheimer's disease, physicians argued. (JAMA)

From March 2020 through June 2021, people with of being hospitalized with and dying from COVID-19 than controls, a study in Wales reported. (Epilepsia)

MRI features distinguished from viral encephalitis and Creutzfeldt-Jakob disease. (JAMA Neurology)

The that combined an amyloid-beta 42/40 ratio and the percent of phosphorylated tau 217 showed an area under the curve of 0.94, yielding 88% agreement with amyloid PET. (Alzheimer's and Dementia)

Risk of was driven more by the number of years in which repetitive head impacts were experienced in contact sports -- especially American football -- than the number of traumatic brain injuries. (Neurology)

A Virginia Commonwealth University-led and other neurodegenerative diseases is poised to become state law. (Virginia Mercury)

  • Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.